US Sen. Amy Klobuchar, the Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, US Sen. Al Franken, and other Democrats urged the Trump administration to investigate the impact of a potential T-Mobile and Sprint merger.
A combination of T-Mobile and Sprint could raise significant antitrust issues and could harm consumers, according to a press release from Klobuchar’s office.
Although a deal has not been announced, the two parties have made repeated attempts to merge, and current reports suggest they are close to an agreement. In a letter, the senators call on Federal Communications Commission (FCC) Chairman Ajit Pai and Assistant Attorney General for the Department of Justice’s Antitrust Division, Makan Delrahim, to begin to examine this potential transaction now.
“Beginning an investigation into a merger of T-Mobile and Sprint now will allow your agencies to quickly, but fully, review the agreement if it is announced,” the senators wrote. “The likelihood of the transaction occurring combined with the serious issues that it raises provide compelling reason for DOJ and the FCC to begin investigating the potential transaction.”
Full Content: Klobuchar
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas